Chemotherapy News and Research

Latest Chemotherapy News and Research

New ecosystem approach to drive antibiotic development

The World Health Organization has deemed antibiotic resistance to be one of the three greatest threats to human health today, as bacteria become increasingly resistant and too few treatments are being developed to combat them.

24 Jan 2018

Combination chemotherapy increases survival in animal models of glioblastoma

A diagnosis of the brain cancer glioblastoma carries a dismal prognosis, with most patients dying within five years.

23 Jan 2018

Exercise could extend the life expectancy of breast cancer survivors, study states

New research conducted by a group of scientists at the University of Southern California (USC), whose findings are published in the Journal of Clinical Oncology, suggests that regular exercise could extend the life expectancy of breast cancer survivors, by lowering their increased risk of type 2 diabetes, heart disease, and potentially breast cancer recurrence.

23 Jan 2018

Researchers block common siren call of glioblastoma and metastatic breast cancer

Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

23 Jan 2018

Researchers show association between microbiome and cancer-related blood infections

Cancer patients receive essential medicines, fluids, blood and nutrients through long, flexible tubes called central venous catheters, or central lines.

22 Jan 2018

Modular gene enhancers may be suitable target in treatment of blood cancer

Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer.

18 Jan 2018

Findings reveal conventional cancer therapy as double-edged sword

Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

18 Jan 2018

Cocaine de-addiction breakthrough shows promise

Researchers have successfully created a way by which cocaine craving could be reduced. This could help in the de-addiction of thousands of users feel experts. The team of researchers neutralized a protein molecule that is commonly seen among cocaine users in their blood and brain.

16 Jan 2018

FDA grants approval for first drug to treat inherited breast cancer

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.

15 Jan 2018

Guts of surfers more likely to be colonized by antibiotic-resistant bacteria, study reveals

Regular surfers and bodyboarders are three times more likely to have antibiotic resistant E. coli in their guts than non-surfers, new research has revealed.

15 Jan 2018

Scientists describe groundbreaking training effect on the innate immune system

"Training" of precursors of white blood cells leads to a sustained positive response of the hematopoietic system. This effect could help accelerate the formation of new white blood cells, which are vitally needed during chemotherapy, a process that can slow down hematopoiesis.

15 Jan 2018

Stem cell transplant can effectively treat patients with rare autoimmune disease, study shows

An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found.

12 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018

BRCA gene mutation does not raise the risk of death

BRCA gene mutation has been associated with cancers such as breast cancer. The BRCA gene mutation detection had resulted in a prophylactic double mastectomy for actress Angelina Jolie anticipating cancer. Now a new study has shown that having a BRCA gene mutation and being diagnosed with breast cancer does not raise the risk of death after diagnosis. The study was published in the latest issue of the journal The Lancet Oncology.

11 Jan 2018

Chemotherapy News and Research

Latest Chemotherapy News and Research

New ecosystem approach to drive antibiotic development

Combination chemotherapy increases survival in animal models of glioblastoma

Exercise could extend the life expectancy of breast cancer survivors, study states

Researchers block common siren call of glioblastoma and metastatic breast cancer

Researchers show association between microbiome and cancer-related blood infections

Modular gene enhancers may be suitable target in treatment of blood cancer

Findings reveal conventional cancer therapy as double-edged sword

Cocaine de-addiction breakthrough shows promise

FDA grants approval for first drug to treat inherited breast cancer

Guts of surfers more likely to be colonized by antibiotic-resistant bacteria, study reveals

Scientists describe groundbreaking training effect on the innate immune system

Stem cell transplant can effectively treat patients with rare autoimmune disease, study shows

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

BRCA gene mutation does not raise the risk of death

Novel antifungal shows promise to stave off drug-resistant superbugs

CAP releases new guideline for HPV testing in patients with head and neck cancers

Researchers discover new promising biomarker for colorectal cancer

Researchers create ‘protocells’ for delivering drugs to deepest tumor regions

Patients with desmoplastic melanoma respond well to immunotherapy

Circadian rhythms could hold key to novel treatments for glioblastoma

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in